BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33584723)

  • 1. Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs.
    Démoulins T; Ruggli N; Gerber M; Thomann-Harwood LJ; Ebensen T; Schulze K; Guzmán CA; McCullough KC
    Front Immunol; 2020; 11():622385. PubMed ID: 33584723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.
    Démoulins T; Milona P; Englezou PC; Ebensen T; Schulze K; Suter R; Pichon C; Midoux P; Guzmán CA; Ruggli N; McCullough KC
    Nanomedicine; 2016 Apr; 12(3):711-722. PubMed ID: 26592962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure.
    Démoulins T; Ebensen T; Schulze K; Englezou PC; Pelliccia M; Guzmán CA; Ruggli N; McCullough KC
    J Control Release; 2017 Nov; 266():256-271. PubMed ID: 28935594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids.
    Englezou PC; Sapet C; Démoulins T; Milona P; Ebensen T; Schulze K; Guzman CA; Poulhes F; Zelphati O; Ruggli N; McCullough KC
    Mol Ther Nucleic Acids; 2018 Sep; 12():118-134. PubMed ID: 30195751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome.
    Démoulins T; Techakriengkrai N; Ebensen T; Schulze K; Liniger M; Gerber M; Nedumpun T; McCullough KC; Guzmán CA; Suradhat S; Ruggli N
    Methods Mol Biol; 2024; 2786():89-133. PubMed ID: 38814391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo.
    McCullough KC; Bassi I; Milona P; Suter R; Thomann-Harwood L; Englezou P; Démoulins T; Ruggli N
    Mol Ther Nucleic Acids; 2014 Jul; 3(7):e173. PubMed ID: 25004099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Replicating RNA Vaccine Delivery to Dendritic Cells.
    Démoulins T; Englezou PC; Milona P; Ruggli N; Tirelli N; Pichon C; Sapet C; Ebensen T; Guzmán CA; McCullough KC
    Methods Mol Biol; 2017; 1499():37-75. PubMed ID: 27987142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases.
    Démoulins T; Schulze K; Ebensen T; Techakriengkrai N; Nedumpun T; Englezou PC; Gerber M; Hlushchuk R; Toledo D; Djonov V; von Gunten S; McCullough KC; Liniger M; Guzmán CA; Suradhat S; Ruggli N
    Nanomedicine; 2023 Apr; 49():102655. PubMed ID: 36681171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.
    Nakamura A; Kotaki T; Nagai Y; Takazawa S; Tokunaga K; Kameoka M
    PLoS One; 2022; 17(10):e0274829. PubMed ID: 36264936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
    Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1).
    Yang SG; Wo JE; Li MW; Mi FF; Yu CB; Lv GL; Cao HC; Lu HF; Wang BH; Zhu H; Li LJ
    Vaccine; 2009 Dec; 27(52):7451-8. PubMed ID: 19450640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replicon particle vaccine protects swine against influenza.
    Bosworth B; Erdman MM; Stine DL; Harris I; Irwin C; Jens M; Loynachan A; Kamrud K; Harris DL
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e99-e103. PubMed ID: 21094422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
    Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
    J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
    Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.
    Crevar CJ; Carter DM; Lee KY; Ross TM
    Hum Vaccin Immunother; 2015; 11(3):572-83. PubMed ID: 25671661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.